Skip to Content

Catching Up with Consulting — DIA 2024 Insights

This article is based on opinions and perceptions from the DIA 2024 Global Annual Meeting, in San Diego, June 2024. Many thanks to our contributors: April Purcell (Specialist) and Michelle Peter (Senior Specialist). The team sat down with Gail Winslow, Head of Marketing, after the conference to share their experiences.  

From start to finish, several key themes emerged. Artificial Intelligence in clinical trials dominated the agenda, mirroring its prominence in many industry events. International collaboration was also a major focus, highlighted by Japan’s PMDA taking a strong stance. Real-world data and real-world evidence were consistent undercurrents, alongside discussions on regulatory guidance and the urgent need to accelerate changes in clinical trials to bring new innovations to market faster and meet patient needs. 

Q: What were the most valuable insights or lessons you learned at the conference? 

Michelle: 

April: 

Q: Was there a particular session or speaker that stood out to you? Why? 

Michelle: 

April:  

Q: Were there any surprising or unexpected topics covered that you found interesting? Or was there anything you thought would be covered and wasn’t? 

Michelle: 

April: 

Q: From what you learned, what is the best advice you would give to your clients having gone to this year’s DIA?  

Michelle: 

Three essential pieces of advice include: 

April: 

Want to learn more about our DIA perspectives? Contact us today.